Teva Pharmaceuticals USA, Inc. recalls Methylphenidate Hydrochloride Extended-Release Capsules (LA), 40 mg, 100 count bottle, Rx only, TEVA PHARMACEUTICALS USA
Recalled August 14, 2013 · FDA recall D-849-2013 · Teva Pharmaceuticals USA
Hazard
Failed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing. · FDA Class II
Units
7,579 bottles
Sold at
Nationwide
Description
Failed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing.
Product
Methylphenidate Hydrochloride Extended-Release Capsules (LA), 40 mg, 100 count bottle, Rx only, TEVA PHARMACEUTICALS USA, NDC 0093-5348-01
Manufacturer(s)
Teva Pharmaceuticals USA, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →